BPH Global Ltd.

BPH Global Ltd (ASX:BP8) entered into a legally binding terms sheet to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners for AUD 0.2 million on September 19, 2023. BPH Global Ltd (ASX:BP8) entered into an agreement to acquire Foshan Gedishi Biotechnology Co Ltd from two China Partners on September 20, 2023. BPH Global will issue 100 million shares as consideration. Completion of the transaction is subject to due diligence on Foshan, any requisite Australian regulatory, ASX, China regulatory approvals and shareholder approvals for the transaction being obtained by BPH and the two China Partners entering into Executive Employment Agreements with Foshan. Completion of the acquisition will take place by October 31, 2023. As of October 20, 2023, Completion of the acquisition is anticipated to occur 2 business days following the Company?s AGM on 21 November 2023 where shareholder approval for the issuance of shares to the vendors is being sought. BPH Global Ltd (ASX:BP8) completed the acquisition of Foshan Gedishi Biotechnology Co Ltd from two China Partners on December 11, 2023.